Immunoprecise Antibodies Ltd IPA:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
4.75quote price arrow down-0.21 (-4.23%)
Volume
22,894
52 week range
3.51 - 16.47
Loading...
  • Open4.84
  • Day High5.00
  • Day Low4.72
  • Prev Close4.96
  • 52 Week High16.47
  • 52 Week High Date07/22/21
  • 52 Week Low3.51
  • 52 Week Low Date03/14/22

Key Stats

  • Market Cap89.72M
  • Shares Out19.46M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-11.19

KEY STATS

  • Open4.84
  • Day High5.00
  • Day Low4.72
  • Prev Close4.96
  • 52 Week High16.47
  • 52 Week High Date07/22/21
  • 52 Week Low3.51
  • 52 Week Low Date03/14/22
  • Market Cap89.72M
  • Shares Out19.46M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-11.19

RATIOS/PROFITABILITY

  • EPS (TTM)-0.70
  • P/E (TTM)-6.78
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immunoprecise Antibodies Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ImmunoPrecise Antibodies Ltd. is a technology platform company that is engaged in the full-service therapeutic antibody discovery. The Company is focused on offering species-agnostic advancements, such as the B cell Select single-cell interrogation technology, DeepDisplay custom phage libraries, as well as the Abthena bispecific program. Its geographical segments include United States of America, Canada and Europe. The Company’s Antibody Discovery offers design, immunization...
James Kuo M.D.
Independent Chairman of the Board
Jennifer Bath Ph.D.
President, Chief Executive Officer, Director
Lisa Helbling
Chief Financial Officer
Kari Graber
Vice President - Client Relations and Project Management
Address
880 - 580 HORNBY STREET
Vancouver, BC
V6C3B6
Canada